SCHEMBL4555834

SCHEMBL4555834

O=C1Nc2c(cc(-c3ccccc3)cc2C(F)(F)F)C1=O

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CES1 P23141 3/20 0.58
MAOA P21397 3/20 0.50
MAOB P27338 3/20 0.50
KDM4E B2RXH2 1/20 0.40
ALDH1A1 P00352 1/20 0.40
GLA P06280 1/20 0.40
GAA P10253 1/20 0.40
HPGD P15428 1/20 0.40
DAO P14920 2/20 0.39
NSD2 O96028 1/20 0.39
BCHE P06276 1/20 0.39
TGM2 P21980 1/20 0.39
DNMT1 P26358 1/20 0.39
LDHA P00338 1/20 0.38
PTP4A3 O75365 1/20 0.37
CASP3 P42574 1/20 0.37
CASP2 P42575 1/20 0.37
CASP7 P55210 1/20 0.37
CASP6 P55212 1/20 0.37
CASP8 Q14790 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4555257 0.76 CES1 (0.57) CES1ALDH1A1DAONSD2BCHE
SCHEMBL4555823 0.74 CES1 (0.66) CES1MAOAMAOBALDH1A1DAO
SCHEMBL4554137 0.74 ALDH1A1 (0.57) CES1MAOAMAOBKDM4EALDH1A1
SCHEMBL4555546 0.74 CES1 (0.56) CES1ALDH1A1DAONSD2BCHE
SCHEMBL594546 0.74 CES1 (1.00) CES1MAOAMAOBKDM4EALDH1A1
Methane SCHEMBL28257010 0.72 CES1 (0.96) CES1MAOAMAOBKDM4EALDH1A1
Toluene SCHEMBL28094090 0.72 CES1 (0.79) CES1MAOAMAOBALDH1A1DAO
Ethane SCHEMBL28094093 0.71 CES1 (0.93) CES1MAOAMAOBALDH1A1DAO
SCHEMBL4555730 0.71 CES1 (0.51) CES1MAOAMAOBKDM4EALDH1A1
SCHEMBL18020095 0.69 MAOA (0.49) CES1MAOAMAOBKDM4EALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2134692-A2 QUINOLINE DERIVATIVES AND PHARMACEUTICAL COMPOSITIONS COMPRISING THEM FOR SELECTIN INHIBITION Wyeth a Corporation of the State of Delaware (US) 2009-12-23 EP disclosed
US-20080255192-A1 2-(1-(4-chlorophenyl)cyclopropyl)-3-hydroxy-8-(trifluoromethoxy)quinoline-4-carboxylic acid; antiinflammtory agents; antagonists of the mammalian adhesion proteins WYETH (US) 2008-10-16 US disclosed
WO-2008121817-A2 QUINOLINE DERIVATIVES AND PHARMACEUTICAL COMPOSITIONS COMPRISING THEM FOR SELECTIN INHIBITION WYETH (US) 2008-10-09 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080255192-A1 2-(1-(4-chlorophenyl)cyclopropyl)-3-hydroxy-8-(trifluoromethoxy)quinoline-4-carboxylic acid; antiinflammtory agents; antagonists of the mammalian adhesion proteins VCAM1, ICAM1, SELE CES1 1128/4885MAOA 1000/4885MAOB 1372/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.